Key Highlights
•
A new study has identified specific genetic variants that are shared between Alzheimer’s disease and major psychiatric disorders like depression and anxiety. This discovery provides crucial clues about the shared biological roots of these conditions, which could lead to more effective treatments that target the underlying causes rather than just the symptoms.
Source →
•
Researchers found that a small molecule called miR-23b-3p acts as a natural brake on an overactive immune response in a serious blood vessel inflammation disease (IgA vasculitis). Restoring levels of this molecule in animal models reduced disease symptoms, pointing to a promising new therapeutic strategy for this condition.
Source →
•
The severity of bronchiolitis, a common respiratory infection in infants, is linked to a malfunction in the body’s immune “checkpoint” system, which normally helps calm down inflammation. This finding could help doctors identify which babies are at risk for more severe illness and may lead to new immune-targeting treatments.
Source →
•
A study in Ethiopia shows that women who survive a life-threatening complication during pregnancy or childbirth have significantly higher levels of disability six months later compared to women without such complications. This highlights a critical need for long-term follow-up care to support mothers’ health well beyond the traditional six-week postpartum period.
Source →
•
A new imaging probe that specifically targets the estrogen receptor and glows in the near-infrared spectrum has been developed for breast cancer. This technology allows for more precise tumor imaging and could help surgeons remove cancerous tissue more completely during operations.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
